查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
神经生物标誌物市场与 COVID-19 影响分析，按类型、按应用、按最终用途、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1335304

神经生物标誌物市场与 COVID-19 影响分析，按类型、按应用、按最终用途、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Neurological Biomarkers Market with COVID-19 Impact Analysis, By Type, By Application, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 318 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年神经生物标誌物市场规模为 56.079 亿美元，2023 年至 2030 年復合年增长率为 15.8%。

神经生物标誌物市场-市场动态：

  • 技术进步不断进步，精准医学不断发展。
  • 生物标誌物（包括生物标誌物特征）的不断进步使得神经系统疾病更容易治疗。因此，可以实现更快的药物开发、早期诊断和无创测试。此外，数字生物标誌物为各製药公司提供了补充信息，以得出临床试验的决策。反过来，这些因素又推动了神经生物标誌物市场的增长。此外，在个性化医疗中，神经退行性疾病的生物标誌物研究是一个很大的进步领域。各种分子已与各种神经退行性疾病相关联并进行了评估。因此，生物製药行业受到精准医学发展的影响。从生物製药到诊断公司，具有多种职能的不同参与者，包括商业运营和研发，将发生巨大的变化。这归因于对市场增长的积极影响。然而，生物标誌物开发週期长和启动成本高预计将抑制市场增长。此外，在多个研究阶段提供资金的组织的广泛存在预计将为市场扩张提供良好的机会。为了支持与阿尔茨海默氏症和大脑衰老的健康差异相关的研究，美国国立卫生研究院 (NIH) 正在提供额外的资金，因此这一因素可能会推动市场的增长。

神经生物标誌物市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，预计全球神经生物标誌物市场在预测期内（2023-2030 年）每年将以 15.8% 左右的复合年增长率增长
  • 由于生物标誌物的不断进步，神经生物标誌物行业预计将以显着的速度增长
  • 根据类型细分，预计基因组将在 2022 年显示出最大的市场份额
  • 根据应用细分，阿尔茨海默病是2022年的主导类型
  • 按地区划分，北美是 2022 年的主要收入来源

神经生物标誌物市场-細項分析：

  • 全球神经生物标誌物市场根据类型、应用、最终用途和区域进行细分。
  • 市场根据类型分为四类：成像、蛋白质组、基因组、代谢组等。在预测期内，基因组部分可能会保持其主导地位。该细分市场为根据个人对疾病的易感性和特定遗传变异开发个性化药物和诊断提供了各种机会。此外，用于鑑定基因组生物标誌物的存在或研究基因组生物标誌物以检测与疾病相关的DNA 序列变异的方法包括使用单核苷酸多态性(SNP) 的全基因组关联研究、阵列比较基因组杂交(CGH)、全基因组重测序和基因表达谱。
  • 根据应用，市场分为四类：多发性硬化症、阿尔茨海默病、自闭症谱系障碍、帕金森病等。阿尔茨海默病领域预计将主导市场。这一增长归因于疾病负担的增加和临床使用产品的可用性，包括用于诊断的成像生物标誌物——淀粉样蛋白 PET 示踪剂。此外，非营利组织和政府组织正在提供大量可能促进市场增长的研究机会。
  • 根据最终用途，市场分为三类：研究组织、医院和医院实验室、独立临床诊断中心等。由于住院人数的增加，医院和医院实验室部门可能会在预测期内保持其主导地位。此外，医疗基础设施的不断发展也增强了医院设施。许多基于血液的生物标誌物检测方法均由医院拥有并大量使用。此外，由于越来越多地采用生物标誌物、门诊手术中心（ASC）和製药公司进行药物发现和开发，研究机构的增长速度最快

神经生物标誌物市场-地理洞察：

从地域上看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

神经生物标誌物市场-竞争格局：

痴呆症、脑肿瘤、偏头痛、癫痫和阿尔茨海默病等神经系统疾病患病率的上升归因于市场的增长。此外，在神经系统疾病中，早期诊断的要求和技术进步等因素也促进了市场的增长。此外，市场参与者采取的策略使他们能够利用导致创新产品的开发并增强其供应链。在此基础上，战略包括推出各种产品、合作、协议、收购和技术进步，以在市场上立足。例如，2020 年 8 月，Enigma Biomedical Group 宣布签署协议，获得杨森的新型神经成像生物标誌物许可。此外，这些生物标记物有望为增进我们对一系列神经退行性疾病（包括阿尔茨海默病和其他痴呆症）的理解提供重要的新工具。

最近的发展：

例如，2021 年 4 月，Quanterix Corp. 举办了一场由顶级行业专业人士参加的网络研讨会，讨论与 pTau181、pTau217、pTau231 和其他神经生物标誌物超灵敏测量相关的神经学进展。

该研究的主要特点：

  • 这项关于神经生物标誌物市场的拟议研究提供了市场规模（百万美元）、年复合成长率（CAGR%）和预测估计（2023-2030），以 2022 年为基准年。
  • 该报告为客户提供了有关神经生物标誌物市场的最新趋势见解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并解释了神经生物标誌物市场有吸引力的投资主张矩阵。
  • 总体报告确定了新的投资机会、老牌参与者面临的挑战以及神经生物标誌物市场维持的增长因素。
  • COVID-19 对神经生物标誌物市场规模、预测、复合年增长率和市场动态的影响将在研究范围下详细讨论。还将涵盖对新冠疫情后神经生物标誌物市场的详细见解。
  • 为了让本报告的用户全面了解神经生物标誌物市场，我们还包括了神经生物标誌物市场的竞争格局和关键创新者分析。
  • 该研究包括增长前景映射分析，其中所有行业细分都根据其市场规模、增长率和吸引力进行基准测试。
  • 该报告提供了主要市场参与者的详细公司概况，这些参与者将帮助用户了解在神经生物标誌物市场运营的参与者的财务信息和战略倡议。
  • 此外，报告还揭示了全球和区域市场主要参与者的重要收购和兼併、合作和合资、新产品推出、研发、区域扩张。
  • 全球神经生物标誌物市场报告主要面向该行业的各个利益相关者，包括供应商、投资者、新进入者、分销商和财务分析师。

目录

第 1 章：神经生物标誌物市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的神经生物标誌物市场片段
    • 神经生物标誌物市场片段（按应用）
    • 按最终用途分類的神经生物标誌物市场片段
    • 按国家/地区分類的神经生物标誌物市场片段
    • 按地区分類的神经生物标誌物市场片段
  • 竞争洞察

第 3 章：神经生物标誌物主要市场趋势

  • 神经生物标誌物市场驱动因素
    • 市场驱动因素的影响分析
  • 神经生物标誌物市场限制
    • 市场限制影响分析
  • 神经生物标誌物市场机会
  • 神经生物标誌物市场未来趋势

第 4 章：神经生物标誌物行业研究

  • PEST分析
  • 波特五力分析
  • 增长前景图
  • 规范架构分析

第 5 章：神经生物标誌物市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的细分市场
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：神经生物标誌物市场格局

  • 2022 年神经生物标誌物市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：神经生物标誌物市场 - 按类型

  • 概述
    • 按类型分類的细分市场份额分析
    • 影像学
    • 蛋白质组学
    • 基因组
    • 代谢组学
    • 其他的

第 8 章：神经生物标誌物市场 -按应用

  • 概述
    • 按应用的细分市场份额分析
    • 多发性硬化症
    • 阿尔茨海默氏病
    • 自闭症谱系障碍
    • 帕金森病
    • 其他的

第 9 章：神经生物标誌物市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 研究机构
    • 医院和医院实验室
    • 独立临床诊断中心
    • 其他的

第 10 章：神经生物标誌物市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场份额分析
  • 北美
    • 概述
    • 北美神经生物标誌物主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲神经生物标誌物主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区神经生物标誌物主要製造商
    • 亚太地区市场规模和预测（按国家）
    • 亚太地区市场规模和预测（按类型）
    • 亚太地区市场规模和预测（按应用）
    • 亚太地区市场规模和预测（按最终用途）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉美
    • 概述
    • 拉丁美洲神经生物标誌物主要製造商
    • 拉丁美洲市场规模和预测（按国家）
    • 拉丁美洲市场规模和预测（按类型）
    • 拉丁美洲市场规模和预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲神经生物标誌物主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 火鸡
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 神经生物标誌物行业

  • 竞争仪表板
  • 公司简介
    • PERKINELMER INC.
    • Abbott Laboratories
    • Quanterix
    • Thermo Fisher Scientific, Inc.
    • Neurobio
    • Banyan Biomarkers, Inc.
    • Bio-Rad Laboratories, Inc.
    • F. HOFFMANN-LA ROCHE LTD.
    • Merck & Co., Inc.
    • DiaGenic ASA
    • Johnson & Johnson Services, Inc.
    • Myriad Genetics, Inc.

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联繫我们
Product Code: ANV1582

REPORT HIGHLIGHT

Neurological biomarkers market size was valued at USD 5,607.9 Million in 2022, expanding at a CAGR of 15.8% from 2023 to 2030.

Neurological biomarkers are the biomarkers used for calculating and evaluating a symptom or method for obtaining a pharmacological response to a particular treatment. Additionally, they are extensively used for the identification of various diseases, such as autism, Parkinson's disease, and depression. Moreover, the general types of neurological biomarkers are metabolomics imaging, genomics, and proteomics.

Neurological Biomarkers Market- Market Dynamics:

  • Increasing Technological Advancements and Increasing Development of Precision Medicine.
  • Increasing advancements in biomarkers, including biomarker signatures, make neurological diseases more treatable. As a result, in faster drug development, early diagnosis, and noninvasive testing. In addition, digital biomarkers provide various pharmaceutical companies as well as supplemental information to conclude the decisions for clinical trials. This, in turn, such factors fuel the market growth of neurological biomarkers. Moreover, in personalized medicine, biomarker research in neurodegenerative disease is a large advancing area. Various molecules have been associated and assessed with varied neurodegenerative disorders. Thus, the biopharmaceutical industry is impacted by the evolution of precision medicine. From biopharma to diagnostics companies' different players with several functions, including commercial operations to research and development will observe a huge change. This is attributed to positively impacting the market growth. However, protracted biomarker development cycles and high startup costs are expected to restrain market growth. Furthermore, the wide presence of organizations offering funds at numerous stages of research is expected to provide a great opportunity for market expansion. To support research associated with health disparities in Alzheimer's and brain aging, the National Institutes of Health (NIH) is providing additional funds, therefore this factor may fuel the market growth.

Neurological Biomarkers Market- Key Insights:

  • As per the analysis shared by our research analyst, the global neurological biomarkers market is estimated to grow annually at a CAGR of around 15.8% over the forecast period (2023-2030)
  • The neurological biomarkers industry is projected to grow at a significant rate due to the increasing advancements in biomarkers
  • Based on type segmentation, genomic was predicted to show maximum market share in the year 2022
  • Based on application segmentation, Alzheimer's disease was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Neurological Biomarkers Market- Segmentation Analysis:

  • The global neurological biomarkers market is segmented on the basis of type, application, end-use, and region.
  • The market is divided into four categories based on type: imaging, proteomic, genomic, metabolomic, and others. The genomic segment is likely to maintain its dominance during the forecast period. The segment provides various opportunities for the development of personalized medicines and diagnostics based on an individual's predisposition to the disease & specific genetic variations. Additionally, methods used for the identification of the presence or studying genomic biomarkers for detecting disease-associated DNA sequence variants include whole-genome association studies using Single Nucleotide Polymorphisms (SNPs), array Comparative Genomic Hybridization (CGH), whole-genome resequencing, and gene expression profiling.
  • The market is divided into four categories based on application: multiple sclerosis, Alzheimer's disease, autism spectrum disorder, Parkinson's disease, and others. The Alzheimer's disease segment is expected to dominate the market. The growth is attributed to the increasing disease burden and product availability for clinical use, including imaging biomarkers-amyloid PET tracers for diagnosis. Moreover, non-profit and government organizations are offering a plethora of research opportunities that may boost market growth.
  • The market is divided into three categories based on end-use: research organizations, hospital & hospital laboratories, independent clinical diagnostic centers, and others. The hospital & hospital laboratories segment is likely to maintain its dominance over the forecast period due to a rise in hospitalization. Additionally, hospital facilities are enhanced by the ongoing development of healthcare infrastructure. Many blood-based biomarker assays are owned by hospitals and utilized in significant volumes. Moreover, research organizations are accounted to the grow at the fastest owing to the rising adoption of biomarkers ambulatory Surgery Centers (ASCs) and pharmaceutical companies for drug discovery & development

Neurological Biomarkers Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Neurological Biomarkers Market- Competitive Landscape:

The rise in the prevalence of neurological diseases like dementia, brain tumors, migraines, epilepsy, and Alzheimer's disease is attributed to the growth of the market. Additionally, in neurological disorders, the factors such as the requirement for early diagnosis and technological advancements are contributing to market growth. Moreover, strategies adopted by market players that allow them to utilize led to the development of innovative products and enhance their supply chain. Based on this, the strategies include the launch of various products, collaboration, agreement, acquisition, and technological advancements to gain a foothold in the market. For instance, in August 2020, Enigma Biomedical Group announced signing an agreement to License Novel Neuro Imaging Biomarkers from Janssen. Additionally, these biomarkers hold great promise to offer essential new tools in the advancement of our understanding of a range of neurodegenerative diseases, including Alzheimer 's disease and other dementias.

Recent Developments:

For instance, in April 2021, Quanterix Corp. introduced a webinar with top industry professionals to discuss neurological advancements related to the ultra-sensitive measurement of pTau181, pTau217, pTau231, and other neurological biomarkers.

Key features of the study:

  • This proposed research study on neurological biomarkers market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the neurological biomarkers market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for neurological biomarkers market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the neurological biomarkers market.
  • Impact of COVID-19 on neurological biomarkers market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on neurological biomarkers market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the neurological biomarkers market, we have also included competitive landscape and key innovator analysis for the neurological biomarkers market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the neurological biomarkers market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global neurological biomarkers market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS

  • PERKINELMER INC.
  • Abbott Laboratories
  • Quanterix
  • Thermo Fisher Scientific, Inc.
  • Neurobio
  • Banyan Biomarkers, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. HOFFMANN-LA ROCHE LTD.
  • Merck & Co., Inc.
  • DiaGenic ASA
  • Johnson & Johnson Services, Inc.
  • Myriad Genetics, Inc.

GLOBALNEUROLOGICAL BIOMARKERS MARKET, BY TYPE

  • Imaging
  • Proteomic
  • Genomic
  • Metabolomic
  • Others

GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY APPLICATION

  • Multiple Sclerosis
  • Alzheimer's Disease
  • Autism Spectrum Disorder
  • Parkinson's Disease
  • Others

GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY END-USE

  • Research Organizations
  • Hospital & Hospital Laboratories
  • Independent Clinical Diagnostic Centers
  • Others

GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Neurological Biomarkers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Neurological Biomarkers Market Snippet by Type
    • 2.1.2. Neurological Biomarkers Market Snippet by Application
    • 2.1.3. Neurological Biomarkers Market Snippet by End-use
    • 2.1.4. Neurological Biomarkers Market Snippet by Country
    • 2.1.5. Neurological Biomarkers Market Snippet by Region
  • 2.2. Competitive Insights

3. Neurological Biomarkers Key Market Trends

  • 3.1. Neurological Biomarkers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Neurological Biomarkers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Neurological Biomarkers Market Opportunities
  • 3.4. Neurological Biomarkers Market Future Trends

4. Neurological Biomarkers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Neurological Biomarkers Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Neurological Biomarkers Market Landscape

  • 6.1. Neurological Biomarkers Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Neurological Biomarkers Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
    • 7.1.2. Imaging
    • 7.1.3. Proteomic
    • 7.1.4. Genomic
    • 7.1.5. Metabolomic
    • 7.1.6. Others

8. Neurological Biomarkers Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Multiple Sclerosis
    • 8.1.3. Alzheimer's Disease
    • 8.1.4. Autism Spectrum Disorder
    • 8.1.5. Parkinson's Disease
    • 8.1.6. Others

9. Neurological Biomarkers Market - By End-use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-use, 2022&2030 (%)
    • 9.1.2. Research Organizations
    • 9.1.3. Hospital & Hospital Laboratories
    • 9.1.4. Independent Clinical Diagnostic Centers
    • 9.1.5. Others

10. Neurological Biomarkers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Neurological Biomarkers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Neurological Biomarkers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Neurological Biomarkers Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Neurological Biomarkers Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Neurological Biomarkers Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Neurological Biomarkers Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. PERKINELMER INC.
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Quanterix
    • 11.2.4. Thermo Fisher Scientific, Inc.
    • 11.2.5. Neurobio
    • 11.2.6. Banyan Biomarkers, Inc.
    • 11.2.7. Bio-Rad Laboratories, Inc.
    • 11.2.8. F. HOFFMANN-LA ROCHE LTD.
    • 11.2.9. Merck & Co., Inc.
    • 11.2.10. DiaGenic ASA
    • 11.2.11. Johnson & Johnson Services, Inc.
    • 11.2.12. Myriad Genetics, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Neurological Biomarkers Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Neurological Biomarkers Market, by Type2018-2030 (USD Million)
  • TABLE Neurological Biomarkers Market: ApplicationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Neurological Biomarkers Market, by Application2018-2030 (USD Million)
  • TABLE Neurological Biomarkers Market: End-use Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-use
  • TABLE Global Neurological Biomarkers Market, by End-use 2018-2030 (USD Million)
  • TABLE Neurological Biomarkers Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Neurological Biomarkers Market, by Region 2018-2030 (USD Million)
  • TABLE North America Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Neurological Biomarkers Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
  • TABLE Europe Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
  • TABLE EuropeNeurological Biomarkers Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
  • TABLE Asia Pacific Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Neurological Biomarkers Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
  • TABLE Latin America Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Neurological Biomarkers Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Neurological Biomarkers Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)

List of Figures

  • FIGURE Neurological Biomarkers Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022&2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022&2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-use segment market share analysis, 2022&2030
  • FIGURE End-use segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Neurological Biomarkers Market share and leading players, 2022
  • FIGURE Europe Neurological Biomarkers Market share and leading players, 2022
  • FIGURE Asia Pacific Neurological Biomarkers Market share and leading players, 2022
  • FIGURE Latin America Neurological Biomarkers Market share and leading players, 2022
  • FIGURE Middle East and Africa Neurological Biomarkers Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Neurological Biomarkers Market share analysis by country, 2022
  • FIGURE Germany Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Neurological Biomarkers Market share analysis by country, 2022
  • FIGURE India Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Neurological Biomarkers Market share analysis by country, 2022
  • FIGURE Brazil Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Neurological Biomarkers Market share analysis by country, 2022
  • FIGURE Saudi Arabia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)